Nifty 17277.95 (0.75%)
Sensex 57858.15 (0.64%)
Nifty Bank 37706.75 (2.05%)
Nifty IT 34707.45 (-0.33%)
Nifty Financial Services 17789.8 (0.89%)
Adani Ports 711.10 (1.23%)
Asian Paints 3147.10 (-0.26%)
Axis Bank 752.20 (6.76%)
B P C L 382.55 (2.53%)
Bajaj Auto 3469.10 (2.57%)
Bajaj Finance 6963.75 (0.46%)
Bajaj Finserv 15528.95 (-1.13%)
Bharti Airtel 711.85 (3.18%)
Britannia Inds. 3539.30 (0.44%)
Cipla 905.65 (1.52%)
Coal India 161.15 (3.10%)
Divis Lab. 4049.20 (-0.18%)
Dr Reddys Labs 4402.85 (0.88%)
Eicher Motors 2692.00 (1.34%)
Grasim Inds 1721.30 (1.81%)
H D F C 2530.60 (-0.36%)
HCL Technologies 1123.70 (-0.11%)
HDFC Bank 1488.05 (0.09%)
HDFC Life Insur. 630.80 (0.51%)
Hero Motocorp 2782.05 (2.80%)
Hind. Unilever 2327.25 (1.87%)
Hindalco Inds. 485.75 (1.54%)
I O C L 121.45 (0.91%)
ICICI Bank 801.65 (0.40%)
IndusInd Bank 884.25 (3.88%)
Infosys 1722.15 (-0.84%)
ITC 214.30 (1.18%)
JSW Steel 631.15 (1.50%)
Kotak Mah. Bank 1854.65 (1.30%)
Larsen & Toubro 1925.30 (1.34%)
M & M 854.50 (-0.02%)
Maruti Suzuki 8602.60 (6.83%)
Nestle India 18790.75 (0.39%)
NTPC 135.30 (2.04%)
O N G C 165.15 (-0.33%)
Power Grid Corpn 218.85 (2.27%)
Reliance Industr 2373.25 (-0.20%)
SBI Life Insuran 1228.00 (0.24%)
Shree Cement 24497.50 (0.73%)
St Bk of India 514.65 (4.15%)
Sun Pharma.Inds. 808.05 (0.90%)
Tata Consumer 707.75 (2.36%)
Tata Motors 490.55 (2.53%)
Tata Steel 1109.10 (0.90%)
TCS 3769.90 (-0.04%)
Tech Mahindra 1500.60 (-0.83%)
Titan Company 2376.50 (-1.10%)
UltraTech Cem. 7098.35 (-0.81%)
UPL 791.15 (3.74%)
Wipro 562.70 (-1.75%)

Supriya Lifescience Ltd IPO

Closed
Subscription Details
  • Open Date 16 Dec
  • Close Date 20 Dec
  • Lot Size 54
  • IPO Size ₹ 700 Cr
  • IPO Price Range ₹ 265 to ₹274
  • Min Investment ₹ 14,310
  • Listing Exchange NSE, BSE

Supriya Lifescience Ltd IPO Timeline

Open Date
16 Dec
Close Date
20 Dec
Basis of Allotment
23 Dec
Refunds
24 Dec
Credit to Demat Account
27 Dec
Listing Date
28 Dec

IPO Synopsis

The active pharmaceuticals manufacturer, Supriya Lifescience Ltd will open its issue for subscription between December 16 and December 20. The company will be listed on the stock exchange on December 28, 2021. The price band for the issue is Rs.265-274 per share with the minimum investment  being Rs.14,796 (54 shares * Rs.274). 
The issue consists of a fresh issue worth Rs.200 crore and an offer for sale worth Rs.500 crore by Satish Waman Wagh, making the total issue worth Rs.700 crore. The promoter holds a stake of 99.98% stake in the company. The book running lead managers to the issue are ICICI Securities Ltd and Axis Capital Ltd. 

Objectives of the issue:
1. Rs.85.38 crore from the net proceeds of the issue is to be used to fund capital expenditure requirements of the company
2. Rs.67 crore is to be used for the repayment and prepayment of debt availed by the company

Supriya Lifescience Ltd IPO Subscription Status

 

Category Subscription Status
Qualified Institutional (QIB) 31.83 Times
Non-Institutional (NII) 161.22 Times
Retail Individual 55.76 Times
Total 71.47 Times

 

Supriya Lifescience IPO Subscription Details (Day by Day)
 

Date QIB NII Retail Total
December 16, 2021 17:00 0.00x 0.66x 11.84x 2.33x
December 17, 2021 17:00 0.53x  2.90x  25.38x  5.69x 
December 20, 2021 17:00 31.83x 161.22x 55.76x 71.47x

About Supriya Lifescience Ltd

Supriya Lifescience, founded in 1987, is one of the key manufacturers and suppliers of active pharmaceutical ingredients (APIs). The company offers 39 APIs which are focused on diverse therapeutic segments like antihistamine, vitamin, anesthetic, anti-asthmatic and anti-allergic. The company is the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride. These account for 45-55% and 65-70% of the exports of API exports of the country between FY17-FY20. In FY20, Supriya Lifescience was one of the largest exporters of Salbutamol Sulphate, in terms of volume. 

In FY21, the company exported its products to 78 countries, 1,060 customers, including 286 distributors. Supriya Lifescience has expanded their API business to Europe, Latin America and North America. Their customers include Syntec Do Brasil LTDA, American International Chemical Inc, AT Planejamento E Desenbolvimento De Negocios Ltda, Mankind Pharma Ltd etc. 

The company has a manufacturing facility in Maharashtra which is spread across 23,806 sq mts. They also operate 5 cleanrooms and are in the process of setting up 2 more new cleanrooms. These 7 are going to be commercialized in FY22. The manufacturing facility of Supriya Lifescience has received approvals from USFDA, EDQM TGA- Australia, KFDA- Korea, PMDA Japan, NMPA- China and Health Canada. 

Supriya Lifescience Ltd Promoter Holding

No data Available

Particulars

(In Rs cr)

FY21

Q3 ended 31 December, 2020

FY20

FY19

Revenue from operations

396.22

255.71

311.64

277.84

PAT

123.83

76.18

73.37

39.42

EPS (In Rs)

-

10.41

10.03

5.39

 

Particulars

(In Rs cr)

Q3 ended 31 December, 2020

FY20

FY19

Total Assets

196.16

336.40

253.05

Total Borrowings

58.43

82.21

89.83

Equity Share Capital

14.63

14.63

14.63

Asset turnover

2.73

3.33

3.41

Debt to Equity ratio

0.25

0.55

0.95

 

Key Ratios

Particulars

 

Q3 ended 31 December, 2020

FY20

FY19

FY18

Gross Margin

63.15%

55.56%

47.14%

36.36%

EBITDA %

42.87%

33.92%

25.45%

13.79%

Profit Margin

28.44%

22.74%

13.79%

3.94%

Current ratio

1.69

1.26

0.98

0.82


Key Points for Supriya Lifesciences IPO are :

Key Points

  • Strengths:

    1. The company has a significant leadership in the niche and key products market. They are the largest exporters of Chlorpheniramine Maleate and Ketamine Hydrochloride
    2. Supriya Lifescience Ltd uses a backward integration model. As of now, 11 of their products, which account for 63.25% of the revenue, are backward integrated
    3. The company has an added advantage of a high geographical diversification as they are spread across 78 countries across the globe
    4. Supriya Lifescience Ltd has a very experienced and skillful operational personnel as well as experienced senior management and promoters

  • Risks:

    1. If the company does not develop new products in time or the already commercialized products are not very well received in the market, it will adversely affect the financials of the company 
    2. A manufacturing or quality control problem will negatively affect the reputation of the company, thus decreasing the goodwill among the customers
    3. A significant amount of revenue is derived from a few specific products and if the demand for these products decrease, this will materially affect the business of the company
    4. Failure to achieve optimal capital utilization or a shutdown or disruption in production will adversely affect the operations of the business

How to Apply for an IPO?

  • Login to your 5paisa account and select the issue in the current IPO section
  • Enter the number of lots and price at which you wish to apply for
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
  • You will receive a mandate notification to block funds in your UPI app
  • You will receive a mandate notification to block funds in your UPI app

Don’t have a Demat account? Open one with 5paisa today!

Keep your documents and get your account activated to start applying for Supriya Lifescience Ltd IPOs in just few hours.

FAQs

What is the issue size of Supriya Lifescience IPO?

The issue size is around Rs.700 crore.

How many shares will I get in 1 lot?

1 lot of Supriya Lifescience IPO has 54 shares. 

When will the share be listed on the stock exchanges?

On December 28 th, 2021, Supriya Lifescience Ltd will be listed on the stock exchanges. 

What is the price of each share going to be?

The price band set for each share of Supriya Lifescience Ltd, is Rs.265-Rs.274 per share. 

Who is the registrar to the offer?

Link Intime India Pvt Ltd is the registrar to the Supriya Lifescience IPO. 

How do I check the allotment status?

Way to check 1-  First you need to go to the registrar’s site- Link Intime India Pvt Ltd and then visit the IPO allotment page. From the drop down menu, select Supriya Lifescience Ltd. Then, enter your PAN card details and select the application type- ASBA or Non-ASBA and enter the required details. After this the status is displayed on the screen.
Way to check 2- Visit the BSE application website page, select equity and then select Supriya Lifescience Ltd from the drop down menu. After entering your PAN card details and application number, the status is displayed on the screen. 

What is the minimum investment required?

The minimum investment required to apply for the Supriya Lifescience Ltd IPO is Rs.14,796. 
It is the upper range of the IPO price i.e. Rs.274*54 shares (1 lot).  Minimum investment in an IPO is the amount of money that you need to invest in order to receive 1 lot of shares of the IPO. The number of shares in 1 lot varies from IPO to IPO but normally, the minimum investment value is calculated by multiplying the number of shares in 1 lot with the upper price range of the IPO price per share. 

Contact Details of Supriya Lifescience Ltd IPO

Contact Information

Address

Supriya Lifescience Limited

207/208, Udyog Bhavan,
Sonawala Road, Goregaon,
East, Mumbai – 400063, Maharashtra, India
Phone: +91-22-40332727
Email: cs@supriyalifescience.com
Website: https://supriyalifescience.com/

Supriya Lifescience Ltd IPO Register

Address

Link Intime India Private Ltd

Phone: +91-22-4918 6270
Email: supriyalife.ipo@linkintime.co.in
Website: https://linkintime.co.in/

Supriya Lifescience Ltd IPO Lead Manager

Axis Capital Limited
ICICI Securities Limited

Have more question about Supriya Lifescience Ltd IPO?

Join 5paisa community and ask your questions